Home / Resources / Videos / ADA 2017 / Henry Anhalt and Howard Steinberg Part 1, Introduction And Insulin For Life

Henry Anhalt and Howard Steinberg Part 1, Introduction And Insulin For Life

In part 1 of this Exclusive Interview, Henry Anhalt and Howard Steinberg talk with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the humanitarian necessity for an organization such as Insulin for Life USA.

Henry Anhalt is a pediatric endocrinologist and board member for Insulin for Life.  Entrepreneur and dLife Founder Howard Steinberg is also a board member on Insulin for Life.

Transcript of this video segment:

Steve Freed:  This is Steve Freed with Diabetes in Control and we’re here in San Diego for the American Diabetes Association 77th Scientific Sessions. We have some really great interviews with some of the top endo’s all across the globe.

We have two special guests here, Henry Anhalt and Howard Steinberg. Some of you may know Howard from the show dLife. So we’ll get started. First tell us a little bit about yourselves.

Henry Anhalt: So I am a pediatric endocrinologist with a particular passion for type 1 diabetes. I’ve been practicing pediatric endocrinology now for over 20 years and I’ve spent some time in biotech as well as in the pharmaceutical industry. I am delighted to be here today to talk about Insulin for Life USA (IFL-USA).

Steve Freed: And Howard, what about you?

Howard Steinberg: I’m an entrepreneur; most of my career has been in marketing and consumer marketing of various kinds. I started a diabetes education and content platform called, dLife several years ago which included a television show, website and many other channels to better engage and empower the diabetes population. I’ve been happily involved with Insulin for Life for the past three years as a board member.

Steve Freed: So tell us a little bit about your organization, Insulin for Life USA.

Henry Anhalt: I think it’s important to recognize, before we go any further, that the challenges around insulin availability across the globe are really challenging and so we take things for granted in the developed world, like in the United States, where people argue about pricing of insulin. But at the end of the day people have access to insulin. As you think outside the bubble of the developed world, you see that there are about 90,000 children across the globe that have absolutely no access to insulin and it’s unconscionable to think that in 2017 there are children dying because of a lack of access to insulin.

Howard Steinberg: Yes, I would just add that it was shocking to me when I got involved. Someone had  just mentioned a statistic to me that a child who discovers type 1 diabetes, maybe not diagnosed, but has type 1 diabetes in Mozambique, for example today, has the same life expectancy as a child diagnosed in the US before the discovery of insulin. That just kind of brought it home and it’s just unconscionable and unacceptable. It’s a humanitarian issue that access to insulin and testing supplies are not universally available.


 Return to the main page.